Please sign in to follow a disease.
New scalp elixir aims to thicken thinning hair
NCT ID NCT07271212
First seen Jun 26, 2026 · Last updated Jul 10, 2026 · Updated 2 times
Summary
This study tests a scalp elixir containing caffeine, panthenol, and growth factors on 60 healthy adults with hair thinning or baldness. Participants apply the product daily for 56 days, and researchers measure oil levels, hair density, thickness, length, and hair loss. The goal is to see if the elixir improves scalp and hair condition.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- caffeine, panthenol, insulin growth factor 1 (IGF-1), and fibroblast growth factor-7 (FGF-7) in a topical scalp elixir
- What this could lead to
- If it works, this could point toward a non-prescription scalp treatment to reduce hair thinning and improve hair density.
- What could go wrong
- This is a small, early-stage trial with only 60 participants and no blinding or placebo control for all groups. Results may not apply to everyone, and the effects may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Nov 2025
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Healthy adults of any gender from the age of 18 to 60 years (inclusive). * Having symptoms of alopecia, baldness, or self-identified with hair thinning. * Absence of chronic diseases, major illnesses, or allergies. * Major illnesses include cancer, post-stroke disorders, paralysis, acute myocardial infarction, coronary artery bypass surgery, end-stage renal disease, and major organ transplant or hematopoietic stem cell transplant Exclusion Criteria: * Currently taking any medication or using any scalp care products * Pregnant or breastfeeding * Chronic diseases, significant illnesses, or allergic constitutions * Currently using scalp care products * Students or employees affiliated with the principal investigator, * Individuals with scalp wounds * Participated in cosmetic product testing * Undergone scalp aesthetic treatments within the past three months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alopecia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hungkuang University
Taichung, 433304, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria supplement tested against chemo hair loss
- Can a serum plus a red light cap regrow hair?
- Scalp cancer surgery that leaves hair follicles behind
- Can a vitamin pill reverse hair loss from Weight-Loss drugs?
- A daily capsule might turn back the clock on skin and hair aging
- A tiny drop of blood might be enough: study tests fingerstick accuracy